Searchable abstracts of presentations at key conferences in endocrinology

ea0037ep773 | Pituitary: clinical | ECE2015

Clinical characterisation of acromegaloidism in a controlled prospective study

Catalina Pablo F , Guanipa Wilfredo , Paramo Concepcion , Gonzalez Enrique Suarez , Matias Lucas Gonzalez , Alvarez Elias , Mallo Federico

Acromegaloidisms are usually reported as isolated cases that are not well characterised clinically. Indeed, most such cases were reported several decades ago, part of the reason why our knowledge about this entity is scarce. By contrast, clinical situations suggestive of acromegaly are not so infrequent, in which basal GH and IGF1 levels lie within a normal range, the GH responses to OGTT challenge are conserved and there is no radiological (MRI) evidence of hypothalamic-pitui...

ea0022p659 | Neuroendocrinology and Pituitary (<emphasis role="italic">Generously supported by Novartis</emphasis>) | ECE2010

Study of pituitary function in acromegaloidism

Sierra Wilfredo Guanipa , Catalina Pablo Fernandez , Fernandez Concepcion Paramo , Garcia Elias Alvarez , Olivie Amalia Andrade , Pena Eduardo , Ferrer Federico Mallo

Acromegaloidism includes clinical features of acromegaly with GH and IGF1 normal levels at baseline and dynamic, without findings of extrapituitary or pituitary tumour. It has been associated with various conditions without a definite pattern. The aim was to evaluate whether there are differences in some hormonal pituitary axis from acromegaloid subjects with respect to acromegalic and healthy subjects. We designed a comparative, multicenter, case–control study in three h...

ea0022p662 | Neuroendocrinology and Pituitary (<emphasis role="italic">Generously supported by Novartis</emphasis>) | ECE2010

Acromegaloidism: description of fifteen cases

Sierra Wilfredo Guanipa , Fernandez Concepcion Paramo , Catalina Pablo Fernandez , Garcia Elias Alvarez , Olivie Amalia Andrade , Pena Eduardo , Ferrer Federico Mallo

Acromegaloidism is a very rare entity (have been 54 cases reported worldwide) that presents with clinical acromegaly and normal somatotropic axis, without findings of pituitary or extrapituitary tumour. Its origin has not been clearly established, although it is associated with several pathophysiological conditions. The local ethics committee approved to perform an observational and multicenter study in three hospitals from a region with approximately 800 000 people over 18 ye...

ea0056p321 | Clinical case reports - Thyroid/Others | ECE2018

Effect of hemoglobin J variant on HbA1c values as measured by HPLC (high-perfomance liquid chromatography)

Ares Blanco Jessica , Bernardo Gutierrez Angel , Martin-Nieto Alicia , Gonzalez-Martinez Silvia , Delgado-Alvarez Elias , Menendez-Torre Edelmiro

Hemoglobin A1c (HbA1c) is used for the long-term management of patients with diabetes mellitus (DM). Hemoglobin variants other than HbA1c and e-N-lysine-glycated HbA0 may cause analytical interference in determinations of HbA1c. Hemoglobin J is an abnormal hemoglobin, an alpha globin gene variant and present in various geographic locations. Hemoglobin J (depending on its type) has different characteristics and functions. For example hemoglobin J Capetown (α2 92Gln β2...

ea0093oc46 | Oral communication 7: Diabetes, Obesity and Metabolism | EYES2023

Glycaemic and inflammatory profile changes in patients with hybrid closed loop systems

Gomez Ana Victoria Garcia , Alarcon Pedro Pujante , Villa-Fernandez Elsa , Goitia Carmen Lambert , Villarino Miguel Garcia , Irusta Alicia Cobo , Alvarez Elias Delgado

Background: the treatment of individuals with type 1 diabetes (T1D) has significantly evolved in recent years. Therefore, with the aim of achieving glycaemic targets to prevent or slow down the progression of the disease and its complications, hybrid closed-loop systems (AID) have been developed. These systems integrate three components: a continuous real-time glucose monitor, a control algorithm and an insulin pump. The objective of this study is to analyse the glycaemic and ...

ea0032oc3.4 | Thyroid | ECE2013

DNA methylation signatures identify biologically distinct thyroid cancer subtypes

Fernandez-Morera Juan Luis , Rodriguez-Rodero Sandra , Alvarez Elias Delgado , Fernandez-Fernandez Agustin , Fernandez-Vega Ivan , Gonzalez-Marquez Rocio , Sanchez-Rivas Veronica , Suarez-Gutierrez Lorena , Rodriguez Caballero Maria Galiana , Blanco Jessica Ares , Fernandez-Fraga Mario , Menendez-Torre Edelmiro

Introduction: The global patterns of aberrant DNA methylation in thyroid cancer are not known. In this study, we have used DNA methylation arrays to determine, for the first time, the genome-wide promoter methylation status of different subtypes of thyroid tumors.Material and methods: We analyzed a cohort of 54 snap frozen thyroid samples (thirteen papillary tumors, six follicular, eleven anaplastic, twenty medullar and four normal tissue samples). Also ...

ea0022p44 | Adrenal | ECE2010

Pheochromocytoma of the adrenal gland scaled score (PASS) as a predictor of aggressive biologic behaviour

Fernandez Maria Riestra , Pallares Pedro Boix , Torre Edelmiro Menendez , Ragnarsson Cecilia Sanchez , Granda Javier Aller , Artal Antonio Rabal , Alvarez Elias Delgado , Corcovado Antonio Lavilla , Petierra de la Uz Joaquin , Felechosa Marta Dieguz , Castaneda Virginia Bellido

Background: Up to 15% of pheochromocytomas are malignant. The only definite criterion for malignancy is the presence of metastases. The histological differentiation between benign and malignant tumours is difficult, being a challenging problem nowadays.Aim: To asses if postoperative histological evaluation using the previously proposed pheochromocytoma of the adrenal gland scales scored (PASS) can predict malignancy.Methods: Twenty...